消息

WOR’s shares traded at $47.64 as of the most recent Friday, marking a 15 % rise over the past year, though the stock has fallen 17 % over the last month and 10 % over three months. An intrinsic‑value analysis puts the fair price near $67.20, implying a 29.1 % undervaluation gap, while a one‑year total shareholder return of 17.6 % signals a longer‑t...

全文

Windsor Advisory Group added 78,197 shares of Worthington Enterprises (NYSE: WOR) in Q4 2025, valuing the purchase at roughly $4.32 million and increasing Windsor’s 13F‑reportable AUM by 17.13 %. The industrial conglomerate reported $1.25 billion in revenue and $106 million in net income for the year, with a diversified portfolio that spans value‑a...

全文

Virgin Galactic Holdings, Inc. (NYSE: SPCE) announced that Megan Prichard will assume the role of Chief Growth Officer, effective April 6. In this newly created position, Prichard will orchestrate the company’s integrated growth and revenue strategy across all business lines, focusing on expanding the existing book of business for research missions...

全文

Astrana Health (NASDAQ:ASTH) reported Q4 results of $950.5 million in revenue, a 42.9 % year‑on‑year increase and a 2.3 % beat on analysts’ revenue estimates. The company’s revenue growth was the fastest among its peers, and EPS also exceeded expectations. Astrana’s fully delegated, payer‑agnostic care model and AI‑enabled technology platform are c...

全文

Since beginning to stake, Stablecoin Development has earned approximately 26.6 million SKY token rewards and currently holds a treasury of 2.06 billion SKY tokens, which accounts for 8.78% of the total circulating supply. The management team projects that the existing liquidity will sustain operations through at least March 2027.

全文

NovaBay Pharmaceuticals (NBY) has rebranded to Stablecoin Development Corporation, changing its ticker to SDEV, and its shares surged 12% on the announcement. The company divested its legacy pharmaceutical brands last year and will now concentrate solely on the Sky protocol ecosystem, a decentralized finance infrastructure centered around the USDS...

全文

In his new role, Tendler will lead the clinical development strategy and operations for the company’s VISTA program, including the Phase 2 anti‑VISTA antibody TBS‑2025 for acute myeloid leukemia (AML). The VISTA program is a central focus for TuHURA, and Tendler’s expertise is expected to accelerate its progress toward later‑stage trials. He will a...

全文

TuHURA Biosciences announced that Dr. Craig Tendler, M.D., will serve as Chief Medical Officer, providing strategic and operational oversight for its clinical programs. Tendler brings 29 years of drug‑development and medical‑affairs experience, having coordinated regulatory approvals for four biologic or cell‑therapy oncology products that generate...

全文

Bank Polska Kasa Opieki (WSE:PEO) experienced a modest upward revision in its valuation metrics. Barclays lifted its fair‑value price target from PLN 225.65 to PLN 233.62, adding new reference points at PLN 237 and PLN 265, and maintained an Overweight rating, signaling confidence in the bank’s execution of its current strategy. In contrast, Citi d...

全文

Yubico (NASDAQ STOCKHOLM: YUBICO) has broadened its “YubiKey as a Service” offering to include two new enrollment solutions: FIDO Pre‑reg—a fully managed service that ships pre‑configured YubiKeys—and an “Enroll” app and SDK that enable IT teams to enroll devices on users’ behalf. These additions aim to simplify onboarding and accelerate the rollou...

全文